Next Choice® Support Materials
Keeping your customers educated
To help you communicate more effectively with your pharmacy customers about emergency
contraception and Next Choice, please use the support materials available below.
To download these materials, simply click on the items below. Printed versions of
these pieces can also be ordered by
calling 866-9WATSON.
Stocking Sheet and Counseling
Checklist
Patient Leaflet/English
Patient Leaflet/En
Español
Patient Counseling Q&A
Card
Pharmacy Poster
Dual Label Dispensing Card
You need Adobe® Reader® installed on your computer
to view these materials, or you may download a copy of the Adobe®
Reader® by clicking the icon below.
Important Safety Information
Next Choice® should not be used by women with a known or suspected pregnancy. Women who become pregnant or complain of lower abdominal pain after taking Next Choice should be evaluated for ectopic pregnancy. Next Choice is not effective in terminating an existing pregnancy, and does not protect against STI/HIV. Next Choice may alter the next expected menses, however, if menses is delayed beyond 1 week, pregnancy should be considered. The most common adverse reactions in the clinical trial were menstrual changes (26%), nausea (23%), abdominal pain (18%), fatigue (17%), headache (17%), dizziness (11%), and breast tenderness (11%).
To report side effects of prescription drugs to the FDA, visit
fda.gov/medwatch or call 1-800-FDA-1088.
For more information about Next Choice, please call our Medical Communications Department at 866-9WATSON.
This Web site is intended for United States Prescribers, Pharmacists & Consumers.
